Literature DB >> 11077036

Can thermodynamic measurements of receptor binding yield information on drug affinity and efficacy?

P A Borea1, A Dalpiaz, K Varani, P Gilli, G Gilli.   

Abstract

The present commentary surveys the methods for obtaining the thermodynamic parameters of the drug-receptor binding equilibrium, DeltaG degrees, DeltaH degrees, DeltaS degrees, and DeltaC degrees (p) (standard free energy, enthalpy, entropy, and heat capacity, respectively). Moreover, it reviews the available thermodynamic data for the binding of agonists and antagonists to several G-protein coupled receptors (GPCRs) and ligand-gated ion channel receptors (LGICRs). In particular, thermodynamic data for five GPCRs (beta-adrenergic, adenosine A(1), adenosine A(2A), dopamine D(2), and 5-HT(1A)) and four LGICRs (glycine, GABA(A), 5-HT(3), and nicotinic) have been collected and analyzed. Among these receptor systems, seven (three GPCRs and all LGICRs) show "thermodynamic agonist-antagonist discrimination": when the agonist binding to a given receptor is entropy-driven, the binding of its antagonist is enthalpy-driven, or vice versa. A scatter plot of all entropy versus enthalpy values of the database gives a regression line with the equation TDeltaS degrees (kJ mol(-1); T = 298.15 K) = 40.3 (+/- 0.7) + 1.00 (+/-0.01) DeltaH degrees (kJ mol(-1)); N = 184; r = 0.981; P < 0.0001 - which is of the form DeltaH degrees = beta. DeltaS degrees, revealing the presence of the "enthalpy-entropy compensation" phenomenon. This means that any decrease of binding enthalpy is compensated for by a parallel decrease of binding entropy, and vice versa, in such a manner that affinity constant values (K(A)) of drug-receptor equilibrium (DeltaG degrees = -RT ln K(A) = DeltaH degrees - TDeltaS degrees ) cannot be greater than 10(11) M(-1). According to the most recent hypotheses concerning drug-receptor interaction mechanisms, these thermodynamic phenomena appear to be a consequence of the rearrangement of solvent molecules that occurs during the binding.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11077036     DOI: 10.1016/s0006-2952(00)00368-3

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  17 in total

1.  Thermodynamic assessment of the stability of thrombin receptor antagonistic peptides in hydrophobic environments.

Authors:  Reinhard I Boysen; Agnes J O Jong; Milton T W Hearn
Journal:  Biophys J       Date:  2002-05       Impact factor: 4.033

2.  Cooperativity in the self-assembly of porphyrin ladders.

Authors:  Amaya Camara-Campos; Christopher A Hunter; Salvador Tomas
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-21       Impact factor: 11.205

Review 3.  Ligand binding assays at equilibrium: validation and interpretation.

Authors:  Edward C Hulme; Mike A Trevethick
Journal:  Br J Pharmacol       Date:  2010-11       Impact factor: 8.739

4.  The Energetics of Chromophore Binding in the Visual Photoreceptor Rhodopsin.

Authors:  He Tian; Thomas P Sakmar; Thomas Huber
Journal:  Biophys J       Date:  2017-07-11       Impact factor: 4.033

5.  Thermodynamics and docking of agonists to the β(2)-adrenoceptor determined using [(3)H](R,R')-4-methoxyfenoterol as the marker ligand.

Authors:  Lawrence Toll; Karolina Pajak; Anita Plazinska; Krzysztof Jozwiak; Lucita Jimenez; Joseph A Kozocas; Mary J Tanga; James E Bupp; Irving W Wainer
Journal:  Mol Pharmacol       Date:  2012-03-20       Impact factor: 4.436

6.  Binding of inositol 1,4,5-trisphosphate (IP3) and adenophostin A to the N-terminal region of the IP3 receptor: thermodynamic analysis using fluorescence polarization with a novel IP3 receptor ligand.

Authors:  Zhao Ding; Ana M Rossi; Andrew M Riley; Taufiq Rahman; Barry V L Potter; Colin W Taylor
Journal:  Mol Pharmacol       Date:  2010-03-09       Impact factor: 4.436

7.  The effect of stereochemistry on the thermodynamic characteristics of the binding of fenoterol stereoisomers to the beta(2)-adrenoceptor.

Authors:  Krzysztof Jozwiak; Lawrence Toll; Lucita Jimenez; Anthony Yiu-Ho Woo; Rui-Ping Xiao; Irving W Wainer
Journal:  Biochem Pharmacol       Date:  2010-02-06       Impact factor: 5.858

8.  Discovering small-molecule estrogen receptor α/coactivator binding inhibitors: high-throughput screening, ligand development, and models for enhanced potency.

Authors:  Aiming Sun; Terry W Moore; Jillian R Gunther; Mi-Sun Kim; Eric Rhoden; Yuhong Du; Haian Fu; James P Snyder; John A Katzenellenbogen
Journal:  ChemMedChem       Date:  2011-03-01       Impact factor: 3.466

9.  Kinetic and thermodynamic rationale for suberoylanilide hydroxamic acid being a preferential human histone deacetylase 8 inhibitor as compared to the structurally similar ligand, trichostatin a.

Authors:  Raushan K Singh; Naveena Lall; Travis S Leedahl; Abigail McGillivray; Tanmay Mandal; Manas Haldar; Sanku Mallik; Gregory Cook; D K Srivastava
Journal:  Biochemistry       Date:  2013-10-31       Impact factor: 3.162

10.  Beyond picomolar affinities: quantitative aspects of noncovalent and covalent binding of drugs to proteins.

Authors:  Adam J T Smith; Xiyun Zhang; Andrew G Leach; K N Houk
Journal:  J Med Chem       Date:  2009-01-22       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.